| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 220.66B | 221.88B | 201.03B | 189.03B | 190.69B | 184.48B |
| Gross Profit | 40.66B | 38.93B | 28.53B | 23.99B | 25.58B | 25.40B |
| EBITDA | 27.77B | 26.86B | 16.57B | 428.00M | 14.68B | 16.49B |
| Net Income | 21.04B | 19.89B | 7.94B | -6.91B | 6.68B | 8.12B |
Balance Sheet | ||||||
| Total Assets | 287.79B | 293.90B | 280.54B | 272.51B | 279.73B | 276.52B |
| Cash, Cash Equivalents and Short-Term Investments | 44.17B | 42.34B | 36.34B | 37.03B | 35.06B | 37.77B |
| Total Debt | 4.05B | 480.00M | 322.00M | 382.00M | 544.00M | 996.00M |
| Total Liabilities | 58.56B | 64.30B | 66.62B | 70.44B | 63.39B | 57.77B |
| Stockholders Equity | 226.17B | 226.57B | 211.10B | 199.44B | 213.23B | 214.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.22B | 10.34B | 2.10B | 6.30B | 7.65B |
| Operating Cash Flow | 0.00 | 22.75B | 13.72B | 6.18B | 7.97B | 9.12B |
| Investing Cash Flow | 0.00 | -11.53B | -6.10B | 4.84B | -4.33B | 6.34B |
| Financing Cash Flow | 0.00 | -7.64B | -7.32B | -7.51B | -8.52B | -7.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥269.76B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥311.06B | 12.00 | 8.70% | 2.28% | 6.50% | 53.04% | |
76 Outperform | ¥96.12B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
72 Outperform | ¥1.30T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥688.05B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |